Is there really a yin and yang to VEGF-targeted therapies?

被引：14

作者：

Ellis, Lee M. ^{[1
]}

Reardon, David A. ^{[2
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Duke Univ, Med Ctr, Durham, NC USA

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 09期

关键词：

TUMOR ANGIOGENESIS; BEVACIZUMAB; INVASION; GLIOBLASTOMA; METASTASIS; EFFICACY;

D O I：

10.1016/S1470-2045(10)70161-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：809 / 811

页数：3

共 13 条

[1]

COHN A, 2010, P CLIN AM SOC ONCO S, V28

[2] Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice [J].

de Groot, John F. ;

Fuller, Gregory ;

Kumar, Ashok J. ;

Piao, Yuji ;

Eterovic, Karina ;

Ji, Yongjie ;

Conrad, Charles A. .

NEURO-ONCOLOGY, 2010, 12 (03) :233-242

[3] HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion [J].

Du, Rose ;

Lu, Kan V. ;

Petritsch, Claudia ;

Liu, Patty ;

Ganss, Ruth ;

Passegue, Emmanuelle ;

Song, Hanqiu ;

VandenBerg, Scott ;

Johnson, Randall S. ;

Werb, Zena ;

Bergers, Gabriele .

CANCER CELL, 2008, 13 (03) :206-220

[4] Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy [J].

Ebos, John M. L. ;

Lee, Christina R. ;

Christensen, James G. ;

Mutsaers, Anthony J. ;

Kerbel, Robert S. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) :17069-17074

[5] Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [J].

Ebos, John M. L. ;

Lee, Christina R. ;

Cruz-Munoz, William ;

Bjarnason, Georg A. ;

Christensen, James G. ;

Kerbel, Robert S. .

CANCER CELL, 2009, 15 (03) :232-239

[6] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma [J].

Friedman, Henry S. ;

Prados, Michael D. ;

Wen, Patrick Y. ;

Mikkelsen, Tom ;

Schiff, David ;

Abrey, Lauren E. ;

Yung, W. K. Alfred ;

Paleologos, Nina ;

Nicholas, Martin K. ;

Jensen, Randy ;

Vredenburgh, James ;

Huang, Jane ;

Zheng, Maoxia ;

Cloughesy, Timothy .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4733-4740

[7] Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) [J].

Grothey, Axel ;

Sugrue, Mary M. ;

Purdie, David M. ;

Dong, Wei ;

Sargent, Daniel ;

Hedrick, Eric ;

Kozloff, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5326-5334

[8] Rapid vascular regrowth in tumors after reversal of VEGF inhibition [J].

Mancuso, Michael R. ;

Davis, Rachel ;

Norberg, Scott M. ;

O'Brien, Shaun ;

Sennino, Barbara ;

Nakahara, Tsutomu ;

Yao, Virginia J. ;

Inai, Tetsuichiro ;

Brooks, Peter ;

Freimark, Bruce ;

Shalinsky, David R. ;

Hu-Lowe, Dana D. ;

McDonald, Donald M. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (10) :2610-2621

[9]

MILES D, TUMOUR REBOUND THERE

[10] Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence [J].

Norden, A. D. ;

Young, G. S. ;

Setayesh, K. ;

Muzikansky, A. ;

Klufas, R. ;

Ross, G. L. ;

Ciampa, A. S. ;

Ebbeling, L. G. ;

Levy, B. ;

Drappatz, J. ;

Kesari, S. ;

Wen, P. Y. .

NEUROLOGY, 2008, 70 (10) :779-787

← 1 2 →